Latest News | Sun Pharma Launches Drug for Advanced Breast Cancer Patients

Mumbai, Jan 11 (PTI) Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced breast cancer.

The company said the generic drug will be available in 75, 100, 125 mgs.

Also Read | Lal Bahadur Shastri Death Anniversary 2023 Quotes & HD Images: Slogans, Photos and Wallpapers To Share Remembering the Indian Freedom Fighter and Former Prime Minister.

Kirti Ganorkar, chief executive of Sun Pharma's domestic business, said the new drug will be priced at an affordable rate but did not disclose the same. Palenotm will address the treatment needs of several advanced breast cancer patients.

The company will also introduce a patient assistance programme that will improve patient compliance and accessibility, Ganorkar added.

Also Read | Auto Expo – The Motor Show 2023 To Be Held From January 13 to 18 in Greater Noida, Will Explore Futuristic Green Tech.

Palbociclib, which is a generic medicine, is approved by the USFDA, EMA and CDSCO in combination with hormonal therapies for patients with hormone receptor positive, human epidermal growth factor receptor, negative locally advanced or metastatic breast cancers.

Breast cancer affects around 0.21 million women every year. Among the total patients, around 50 per cent are hormone receptor positive, the major subtype in breast cancer.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)